

Gene Profiling May Predict Treatment Response in Refractory Rheumatoid Arthritis

Conservation of Drugs: The Impact of Acute Immunomodulator Prescribing for COVID-19 on Rheumatology Patients

Does Switching from IV to Subcutaneous Tocilizumab Affect RA Disease Flare?

Atypical Giant Cell Arteritis Case Illustrates Diagnosis, Management Challenges

Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease
ACR Guidance on Tocilizumab Allocation During Shortage
EU Evaluates Tocilizumab as COVID-19 Treatment

ACR Update on Tocilizumab Shortages

Efficacy of Tocilizumab Monotherapy After Ultra-Short Glucocorticoid Administration in GCA
- 1
- 2
- 3
- …
- 7
- Next Page »